Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949243 · ClinicalTrials.gov registry record
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 338
- Enrollment target
NCT04949243: Completed study, sponsored by Duke University.
NCT04949243 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04949243 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
This observational, cohort sub-studyis embedded within a larger public health intervention that distributes at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communitiesthrough the CDC.Within this sub-study, we will evaluate the socio-behavioral mechanisms of SARS-CoV-2 community transmission, including social interactions, health behaviors, healthcare utilization, knowledge, disease burden, and feasibility of at-home testing. The study hypothesis is that positive at-home test results will be associated withaltered self-reported social interactions and altered health behaviors compared to negative test results. Surveys and questionnaires will be completed by participants through the smartphone app or via call center phone calls according to the schedule of events.Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Primary Outcome
Number of participants who reported at their first follow-up assessment as having close contact (within 6 feet) with people who do not live with them.
Interventions
- BEHAVIORAL Behavioral questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2021-04-04 |
| Est. Completion | 2021-11-23 |
What the finished NCT04949243 record still lists
NCT04949243 is an observational study that tracks outcomes without assigning an intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Behavioral questionaires is the first listed.
NCT04949243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04949243 about?
NCT04949243 is a clinical study titled "Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing". This observational, cohort sub-studyis embedded within a larger public health intervention that distributes at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communitiesthrough the CDC.Within this sub-study, we will evaluate the socio-behavioral mechanisms...
What is the current status of trial NCT04949243?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2021-04-04. Estimated completion is 2021-11-23.
What interventions are being tested in trial NCT04949243?
The interventions under investigation include: Behavioral questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT04949243?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI